Field Medical Inc., a pioneer in cardiac pulsed field ablation (PFA) technology, today announced the successful closing of ...

The following is a summary of "Novel Right Ventricular Function Parameters Can Identify Short-Term Non-Responders To ...

Imricor Medical Systems announced that it commenced a trial by completing its first-in-human ventricular ablation procedure.

Wide complexes; because they come from the ventricles and do not use the normal ventricular conduction system, action potentials need to travel from myocyte to myocyte, which is much slower ...

"Now, the WiSE System brings a leadless solution to left ventricular pacing, eliminating the biggest limitation of conventional CRT: the lead. This is a game-changer for patients who were ...

Patients with structural heart disease are at risk for life-threatening ventricular tachycardias (VTs). Implantable cardioverter-defibrillators (ICDs) can terminate VT, but often at the cost of ...

Supira said it plans to use the funding for a pivotal trial of its system and support the future ... "Supira Medical nets $120m to advance ventricular support device" was originally created ...

The Shifamed portfolio company’s percutaneous ventricular assist device ... The company said it has already treated 70 patients with its system in South American trials. The financing was ...

The FieldForce™ Ablation System is an investigational device and is limited by federal (or United States) law to investigational use. The Growing Prevalence of VT and AF Ventricular tachycardia ...